Summary:
Citius TransNet InvIT's ₹1,105 crore initial public offering (IPO) is yet another road infrastructure investment trust entering the capital markets after recent offerings by its competitors, such as Raajmarg, Anantam, and Bharat Highways. The subscription period began on April 17 and ends on April 21, giving investors a chance to invest in a yield-based infrastructure company with growth opportunities.
Citius TransNet InvIT received commitments worth ₹497.25 crore from anchor investors on April 16. The issue consists of 75% for qualified institutional buyers and the rest for non-institutional investors. The key highlight of this IPO is that it does not have any retail investor allocation, and a minimum bid of ₹14,850-15,000 for 150 units is required. If one considers the maximum price band of ₹99-100 per unit, the post-IPO market capitalisation turns out to be approximately ₹6,100 crore.
From a total issue size of ₹1,105 crore, up to ₹1,000 crore of the total will be deployed towards partial or complete acquisition of securities of one entity and some designated projects. In essence, this funding will focus on buying out sponsor securities from SPVs, and not as a pure exercise in deleveraging.
In the post-restructuring scenario, the trust shall own a total of 10 roads, of which seven are toll roads and three are annuity roads. As for the sponsor of the project, Epic TransNet Infrastructure will own at least 15% of the stake post-issue. Additionally, there is also a pipeline of acquisitions from EAAA India Alternatives.
The initial portfolio consists of 3,406.7 lane kilometers and consists largely of toll assets which account for almost 88% of the total revenue earned by the trust from its operations till the month of September 2026. This imbalance gives room for greater growth through toll revenues based on the traffic volume but makes the trust vulnerable to economic fluctuations and traffic interruptions.
There are eleven Hybrid Annuity Model assets spread across 2,366.81 lane kilometers which have been put under the RoFO of Citius. In FY25, these assets earned the trust close to ₹890 crores in annuities.
Enterprise value of the initial portfolio based on the independent valuer’s assessment comes to ₹10,494 crore. Taking into account estimated FY27 EBITDA of ₹1,865 crore, the forward EV/EBITDA ratio would amount to 5.6x, making it lower than the range of peer road InvIT valuation multiples, which lie between 6x and 11x.
Valuation of the company itself is estimated by management at ₹10,347 crore – a bit lower than that provided by the independent valuer due to relatively short concession periods for some projects.
As far as financial metrics are concerned, the portfolio is estimated to produce enterprise free cash flows worth ₹1,200 crore on average, yielding an average enterprise FCF yield of about 11% in FY27-31. After subtracting interest expenses and principal amortizations, FCF yields available to investors are likely to stay within a sustainable 8-9% range.
InvITs are mandated to distribute 90% of their net distributable cash flows, making them hybrid instruments combining features of equity and fixed income. As a result, Citius is not a high-compounding stock but rather a steady income-generating asset with modest capital appreciation potential.
The investment case is better suited for investors with a 4–5 year horizon seeking regular income. However, returns are sensitive to interest rate movements, as rising rates can compress valuations by making fixed-income alternatives more attractive.
Since InvITs must pay out 90% of their net distributable cash flow, they become hybrid securities that have characteristics of both stocks and bonds. Thus, while Citius is not an asset with significant compounding capacity, it is one that generates consistent income with a little capital appreciation upside.
It is a good buy for someone looking for investment opportunities over a period of 4–5 years. But since the performance of Citius is dependent on changes in interest rates, any increase in interest rates would impact its valuation adversely.
One risk that the company faces is the limited period over which the road concessions are available. Some of the assets are only a few years from expiration. For example, Panipat Elevated Corridor expires in January 2027, and other assets such as Rajkot-Vadinar, Dhola, Dibang and Jorabat Shillong will expire in FY29 to FY31. Long-term visibility of the cash flows depends on the acquisition of additional assets.
Concentration of revenue is another risk. Two assets located in Gujarat are responsible for generating more than one-third of the company's revenues, while the top five assets generate over 73% of the revenues forecasted in FY27. Therefore, the company relies heavily on these corridors.
Maintenance expenses may also influence the company's free cash flows. Such expenses are cyclical and lead to declines in the free cash flows. The major maintenance exercise that is likely to take place in FY29 will see a sharp drop in free cash flow despite the increase in EBITDA.
Finally, debt is still a significant concern. Net debt stood at ₹4,247 crore as of 9MFY26 with net debt to FY25 EBITDA ratio at around 3.7x. Although this is typical of InvITs, financing costs become very relevant.
Citius TransNet InvIT appears to be a relatively well-valued investment vehicle within the Indian roads InvIT universe, providing a balanced combination of income and growth prospects.
Nevertheless, its investment proposition is dependent on growth in traffic volumes along specific corridors, prudent acquisitions of additional assets, successful refinancing of existing liabilities, and renewal of expired leases.
The InvIT is far from being an easy money-making venture, and one needs to keep track of various business and financial indicators.
For those looking for dependable cash flow generation alongside capital appreciation over a period of 4-5 years, the listing might serve as a good investment choice, given that the risks involved are acceptable to them.

State Bank of India Subsidiary SBI Funds Management Limited Files DRHP for IPO; SBI to Divest 6.3% Stake via OFS
3 min Read Mar 20, 2026
NSE IPO: Board Meeting on February 6 to Start Long-Awaited Listing Process
2 min Read Feb 5, 2026
SEBI Clears the Way for NSE IPO After Nearly a Decade
3 min Read Feb 1, 2026
Shadowfax Technologies IPO Makes Weak Market Debut: Lists at 9% Discount to IPO Price
3 min Read Jan 28, 2026
First FY26 Annual Results: Companies Reporting Their Full-Year Numbers in April 2026
3 min Read Apr 7, 2026
Omnitech Engineering IPO 2026 Opens Feb 25: ₹583 Crore Issue, Price Band ₹216–227, Listing on NSE & BSE
3 min Read Feb 25, 2026
Clean Max Enviro Energy Solutions IPO Opens on February 23; Issue Size ₹3,100 Crore
3 min Read Feb 23, 2026
Shree Ram Twistex Ltd. ₹110 Crore IPO Opens Feb 23: Price Band ₹95–104, Full Details
3 min Read Feb 23, 2026
Gaudium IVF IPO Closes Tomorrow: Expansion-Focused IVF Chain Taps Market with ₹165 Crore Offer
3 min Read Feb 23, 2026
PFC and REC Merger: What It Means for Shareholders
4 min Read Apr 20, 2026
Why Chemical Sector Ends in Red on April 20, 2026
4 min Read Apr 20, 2026
Why IEX Share Price Fall Up to 8% on Monday?
4 min Read Apr 20, 2026
Bharat Heavy Electricals Share Price Hit 52-Week High - Here is Why
4 min Read Apr 20, 2026
HEG, Graphite India, Triveni Turbine & Jyoti CNC Lead Top Gainers; IEX, GMDC & Cohance Among Top Losers
4 min Read Apr 20, 2026